The Effects of Laughter Therapy on Hemodialysis on Depression

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

152 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-04-01

Study Completion Date

2019-03-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

End stage kidney disease is associated with increased depression. Laughter is associated with improvement in depression in chronic disease. The study objective was to measure the effect of intradialytic group laughter therapy on anxiety and depression. Pragmatic randomized controlled trial conducted in 10 hemodialysis centers in Northern California. The intervention group received a once weekly 30-minute long group laughter therapy session for 8 weeks. Primary outcome was depression score as measured using the Patient Health Questionnaire.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Morbidity and Mortality Among Dialysis Patients After Treatment for Depression

NCT00442429

Depression ESRD

UNKNOWN

Cognitive Behavioral Treatment of Depression in ESRD Patients on Dialysis

NCT00618475

End Stage Renal Disease Depression

COMPLETED NA

Feasibility RCT of ACT Self-help for Depression in Haemodialysis

NCT02565056

End-stage Renal Disease Depression

COMPLETED NA

Impact and Mechanism of Depression on Cardio-cerebral Vascular Events and Arteriovenous Fistula Dysfunction in MHD Patients

NCT06070805

Cardio-cerebral Vascular Events Arteriovenous Fistula Dysfunction

COMPLETED

Exploration of the Potential Mechanisms of n-3 Fatty Acids Supplementation in Depression and Cognitive Function in Patients With Late-life Depression

NCT05972798

Late Life Depression

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

End Stage Kidney Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Outcome Assessors

Statistical Analysis Blinded

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

Once weekly 30-minute long group laughter therapy session for 8 weeks while patients are on dialysis

Group Type EXPERIMENTAL

Laughter Therapy

Intervention Type BEHAVIORAL

Once weekly 30-minute long group laughter therapy session for 8 weeks

Usual Care

Usual care

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Laughter Therapy

Once weekly 30-minute long group laughter therapy session for 8 weeks

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of end stage kidney disease (ESKD) and currently undergoing hemodialysis at a Satellite Healthcare Hemodialysis Center
* Ability to understand English